Emerging Markets Offer High Growth Opportunities for Players in the Atherectomy Devices Market

The growth of the atherectomy devices market is mainly attributed to factors such as growing burden of vascular diseases, increasing availability of reimbursements for atherectomy procedures across mature markets, and increasing commercialization of atherectomy devices.

The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from 1.08 billion in 2017, at a CAGR of 6.1%.

In this report, the market is segmented by product, application, end user, and region.

Based on product, the market is segmented into directional, orbital, photo-ablative (laser), rotational atherectomy devices, and support devices. The directional atherectomy systems segment is expected to account for the largest share of the global atherectomy devices market in 2017. 

The dominant market position of this segment is attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technological advancements in the field of directional atherectomy.

Based on application, the market is segmented into peripheral vascular, cardiovascular, and neurovascular applications. In 2017, the peripheral vascular applications segment is projected to account for the largest share of the market. 

The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment, rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries, and growing patient preference for minimally invasive surgical procedures.

On the basis of end user, the market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment is expected to grow at the highest CAGR during the forecast period. 

The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.

In 2017, the Asia Pacific region is expected to emerge as the new revenue-generating segment for prominent market players. The highest CAGR for the APAC atherectomy devices market can be attributed to the factors such as the presence of increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html